|
Christine Abizaid
|
executive |
USAA Small Cap Stock Fund Institutional Class Shares (UISCX) |
UISCX |
FUND |
Purchase
|
Jan. 31, 2022 |
$$1,001 - $15,000 |
March 19, 2022 |
|
Christine Abizaid
|
executive |
USAA Managed Allocation Fund (UMAFX) |
UMAFX |
FUND |
Purchase
|
Jan. 31, 2022 |
$$1,001 - $15,000 |
March 19, 2022 |
|
Mark Dr Green
|
house |
PbF logistics lP Common units representing limited partner interests (PbFX) |
PbFX |
STOCK |
Sale
|
Jan. 28, 2022 |
$$100,001 - $250,000 |
Feb. 8, 2022 |
|
Josh Gottheimer
|
house |
Freeport-McMoRan, Inc. (FCX) |
FCX |
STOCK |
Sale (partial)
|
Jan. 28, 2022 |
$$1,001 - $15,000 |
Feb. 18, 2022 |
|
Josh Gottheimer
|
house |
Netflix, Inc. (NFLX) |
NFLX |
STOCK |
Sale
|
Jan. 28, 2022 |
$$1,001 - $15,000 |
Feb. 18, 2022 |
|
Donald Sternoff Beyer
|
house |
VanEck Biotech ETF |
XBI |
ETF |
Sale
|
Jan. 28, 2022 |
$$1,001 - $15,000 |
Feb. 1, 2022 |
|
Robert J. Wittman
|
house |
SPdR Select Sector Fund - Energy Select Sector (XlE) |
XLE |
ETF |
Purchase
|
Jan. 28, 2022 |
$$1,001 - $15,000 |
Feb. 13, 2022 |
|
Michael T. McCaul
|
house |
QUEST DIAGNOSTICS INC |
DGX |
STOCK |
PURCHASE
|
Jan. 28, 2022 |
$$1,000-815,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
FEDERAL EXPRESS CORP & CO |
FDX |
STOCK |
PURCHASE
|
Jan. 28, 2022 |
$$1,000-815,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
RAYTHEON CORP |
RTX |
STOCK |
PURCHASE
|
Jan. 28, 2022 |
$$1,000-815,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
NEUROCRINE BIOSCIENCES INC |
NBIX |
STOCK |
Purchase
|
Jan. 28, 2022 |
$$1,000-15,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
BOSTON SCIENTIFIC CORP |
BSX |
STOCK |
Purchase
|
Jan. 28, 2022 |
$$1,000-15,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
QUEST DIAGNOSTICS INC |
DGX |
STOCK |
PURCHASE
|
Jan. 28, 2022 |
$$1,000-515,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
NEUROCRINE BIOSCIENCE INC |
NBIX |
STOCK |
PURCHASE
|
Jan. 28, 2022 |
$$1,000-515,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
CHEVRON CORPORATION |
CVX |
STOCK |
Purchase
|
Jan. 28, 2022 |
$$1,000-15,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
CHEVRON CORPORATION |
CVX |
STOCK |
Purchase
|
Jan. 28, 2022 |
$$1,000-15,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
CHEVRON CORPORATION |
CVX |
STOCK |
Purchase
|
Jan. 28, 2022 |
$$1,000-15,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
CHEVRON CORPORATION |
CVX |
STOCK |
Purchase
|
Jan. 28, 2022 |
$$1,000-15,000 |
Feb. 23, 2022 |
|
Donald Sternoff Beyer
|
house |
iShares MSCI ACWI ex US Healthcare ETF (AXHE) |
AXHE |
ETF |
Sale
|
Jan. 27, 2022 |
$$1,001 - $15,000 |
Feb. 1, 2022 |
|
Donald Sternoff Beyer
|
house |
iShares MSCI ACWI ex US Telecommunication Services ETF (AXTE) |
AXTE |
ETF |
Sale
|
Jan. 27, 2022 |
$$1,001 - $15,000 |
Feb. 1, 2022 |
|
Mark Dr Green
|
house |
PbF logistics lP Common units representing limited partner interests (PbFX) |
PbFX |
STOCK |
Sale
|
Jan. 27, 2022 |
$$250,001 - $500,000 |
Feb. 8, 2022 |
|
Josh Gottheimer
|
house |
Lam Research Corporation (LRCX) |
LRCX |
STOCK |
Sale
|
Jan. 26, 2022 |
$$1,001 - $15,000 |
Feb. 18, 2022 |
|
Thomas R Carper
|
senate |
SPDR S&P Aerospace & Defense ETF |
XAR |
ETF |
Sale (Full)
|
Jan. 26, 2022 |
$$1,001 - $15,000 |
Feb. 3, 2022 |
|
Thomas R Carper
|
senate |
Goldman Sachs Emerging Markets Equity Fund Insti |
GSEMX |
FUND |
Sale (Full)
|
Jan. 26, 2022 |
$$1,001 - $15,000 |
Feb. 3, 2022 |
|
Thomas R Carper
|
senate |
Western Asset Inflation-Linked Opportunities & Inc |
WATLX |
FUND |
Purchase
|
Jan. 26, 2022 |
$$1,001 - $15,000 |
Feb. 3, 2022 |